Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: Results of an international randomized phase II trial (JASINT1)

De Santis M.Wiechno P.J.Bellmunt J.Lucas C.Su W.-C.Albiges L.CHIA-CHI LINSenkus-Konefka E.Flechon A.Mourey L.Necchi A.Loidl W.C.Retz M.M.Vaissi?re N.Culine S.2022-09-152022-09-1520160923-7534https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959923381&doi=10.1093%2fannonc%2fmdv609&partnerID=40&md5=7499cbd4d4e635b63e0b1cd9b111bf2chttps://scholars.lib.ntu.edu.tw/handle/123456789/620297Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: Results of an international randomized phase II trial (JASINT1)journal article10.1093/annonc/mdv609266733522-s2.0-84959923381